Nieminen et al., 1996 - Google Patents
Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitisNieminen et al., 1996
- Document ID
- 18032882945742496734
- Author
- Nieminen A
- Asikainen S
- Torkko H
- Kari K
- Uitto V
- Saxén L
- Publication year
- Publication venue
- Journal of clinical periodontology
External Links
Snippet
In our previous study, we reported that only 13 of 46 adult patients with advanced periodontitis responded well to initial non‐surgical periodontal therapy. In the present follow‐ up study, the remaining 33 patients were randomly treated further using either modified …
- 201000001245 periodontitis 0 title abstract description 40
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Christersson et al. | Subgingival distribution of periodontal pathogenic microorganisms in adult periodontitis | |
Genco et al. | Use and interpretation of microbiological assaysin periodontal diseases | |
Loesche et al. | Trypsin‐Like Activity in Subgingival Plaque: A Diagnostic Marker for Spirochetes and Periodontal Disease? | |
Kido et al. | Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease | |
Vernal et al. | Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients | |
Wolff et al. | Natural distribution of 5 bacteria associated with periodontal disease | |
Dahlén et al. | Putative periodontopathogens in “diseased” and “non‐diseased” persons exhibiting poor oral hygiene | |
Plagnat et al. | Elastase, α2‐macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis | |
Grigoriadou et al. | Interleukin-1 as a genetic marker for periodontitis: review of the literature | |
Lamster et al. | Development of a risk profile for periodontal disease: microbial and host response factors | |
Boillot et al. | Periodontal microbiota and phospholipases: the oral infections and vascular disease epidemiology study (INVEST) | |
Nieminen et al. | Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis | |
Ellwood et al. | Prevalence of suspected periodontal pathogens identified using ELISA in adolescents of differing ethnic origins | |
Wilton et al. | Specific antibody responses to subgingival plaque bacteria as aids to the diagnosis and prognosis of destructive periodontitis | |
Kazor et al. | The prevalence of BANA‐hydrolyzing periodontopathic bacteria in smokers | |
Lamster et al. | Serum IgG antibody response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis: implications for periodontal diagnosis | |
Loesche et al. | The optimization of the BANA test as a screening instrument for gingivitis among subjects seeking dental treatment | |
Sarlati et al. | Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid | |
Lamster et al. | Current status of tests for periodontal disease | |
Giannobile et al. | Glycosaminoglycans and periodontal disease: analysis of GCF by safranin O | |
Kuru et al. | Microbiological features and crevicular fluid aspartate aminotransferase enzyme activity in early onset periodontitis patients | |
Vincent et al. | Effect of periodontal therapy on specific antibody responses to suspected periodontopathogens | |
Lai et al. | Serum IgA and IgG antibodies to Treponema vincentii and Treponema denticola in adult periodontitis, juvenile periodontitis and periodontally healthy subjects | |
Behfarnia et al. | Comparative evaluation of IFNγ, IL4 and IL17 cytokines in healthy gingiva and moderate to advanced chronic periodontitis | |
Sakai et al. | Porphyromonas gingivalis‐specific IgG subclass antibody levels as immunological risk indicators of periodontal bone loss |